DaVita HealthCare Partners Inc (DVA) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.

Total Revenue Chart for DaVita HealthCare Partners Inc

DaVita HealthCare Partners Inc (DVA) revenue for FY2025 was USD 13.6B, a 6.5% change from FY2024. DaVita HealthCare Partners Inc's revenue grew from USD 99.0M in 1994 to USD 13.6B in 2025 (13680.9% over 31 years). Earnings per share grew from USD 0.07 in 2000 to USD 8.48 in 2025 (12357.8%). Revenue compound annual growth rate: 5-year CAGR of 3.4%, 10-year CAGR of -0.1%, 20-year CAGR of 7.9%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$11.60B
Implied Share Price
$180.67
Enterprise Value
$27.35B
Revenue (TTM)
$14.01B
EBITDA
$2.83B
Profit Margin
6.05%
Trailing P/E
16.00
Forward P/E
15.72
Price/Book (MRQ)
91.65
Price/Sales (TTM)
0.82
EV/EBITDA
9.87
EV/Revenue
1.95
Dividend Yield
—
Book Value
$-11.41
Free Cash Flow (FY2025)
$1.31B
Free Cash Flow Yield
11.30%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.